Hind Salama1,2,3,4, Saleem Eldadah5,3,4, Mohamed H. Omer6, Ayman Alhejazi1,2,3,4, Luluh Bin Dayil7, Ayman Almozaini1, Roaa Reda Khalil5, Areej Al Mugairi2,8, Mohammed Snnallah1, Moussab Damlaj1,3,4,9, Ahmed Alaskar1,2,3,4, Ahmad Alsaeed5,2,3,4, Mohammed Mosa Bakkar1,2,3,4, Bader Alahmari1,2,3,4, Mohsen Alzahrani1,2,3,4, Ihab Elhemaidi5,2,3,4, Majed Alahmadi5,2,3,4, Sameer Alamoudi5,2,3,4, Walaa Rajkhan5,2,3,4, Manar Khalil5,3,4
1Department of Oncology, King Abdulaziz Medical City, Ministry of the National Guard Health Affairs, Riyadh, Saudi Arabia
2College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Saudi Arabia
3King Abdullah International Medical Research Center, Saudi Arabia
4Saudi Society of Blood and Bone Marrow Transplantation (SSBMT), Saudi Arabia
5Department of Adult Hematology and Stem Cell Transplantation, Princess Noorah Oncology Center, Ministry of the National Guard Health Affairs, Jeddah, Saudi Arabia
6School of Medicine, Cardiff University, Cardiff, United Kingdom
7Department of Adult Nursing, King Abdulaziz Medical City, Ministry of the National Guard Health Affairs, Riyadh, Saudi Arabia
8Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Ministry of the National Guard – Health Affairs, Riyadh, Saudi Arabia
9Department of Hematology Oncology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates
